On 6 June 2025, the European Commission published two Scientific Committee on Consumer Safety (SCCS) opinions open for comments until 18 August 2025. The ingredients assessed are Tea Tree Oil and Prostaglandin Analogues. Comments can be submitted directly to the contacts provided by the Commission by specifying the SCCS Number (consult the following links for the full opinion on Tea Tree Oil and on Prostaglandin Analogues).
SCCS opinion on Tea Tree Oil
Tea Tree Oil (also referred as “TTO”) is considered as an anti-seborrheic and anti-microbial agent. The SCCS considers its use in cosmetics is safe up to the maximum concentration of:
- 2.0% in shampoo
- 1.0% in shower gel
- 1.0% in face wash
- 0.1% in face cream
SCCS opinion on Prostaglandin Analogues
The Prostaglandin Analogues (PGAs) taken into consideration are Isopropyl Cloprostenate, Norbimatoprost, and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide. The SCCS opinion issued states that none of three PGAs can be considered safe for use in cosmetic products intended for promoting the growth of eyelashes and eyebrows.
Do you have questions on the regulatory status of TTO and PGAs in the EU? Contact us here or at coslaw@obelis.net.
Leave a Reply